Treatment of congenital ichthyosis with acitretin: a case report

dc.contributor.authorCakmak, A.
dc.contributor.authorBaba, F.
dc.contributor.authorCakmak, S.
dc.contributor.authorShermatov, K.
dc.contributor.authorKarazeybek, H.
dc.date.accessioned2024-04-24T17:39:59Z
dc.date.available2024-04-24T17:39:59Z
dc.date.issued2010
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe authors assessed the clinical efficacy, tolerability and safety of acitretin in a patient with ichthyosis. A newborn infant with ichthyosis who presented at birth with collodion baby appearance, was treated with acitretin. A moderate response to acitretin therapy (1 mg/kg/day) administered for 6 months was observed, with improvement in cutaneous lesions. Clinical improvement was achieved shortly after treatment. The treatment resulted in a satisfactory improvement in the skin condition of the case. The tolerance to the drug was good. Side effects were not observed. The oral acitretin treatment is efficient in severe congenital ichthyosis.en_US
dc.identifier.endpage603en_US
dc.identifier.issn0026-4946
dc.identifier.issue6en_US
dc.identifier.pmid21042273
dc.identifier.scopus2-s2.0-79251524916
dc.identifier.scopusqualityN/A
dc.identifier.startpage599en_US
dc.identifier.urihttps://hdl.handle.net/11468/21499
dc.identifier.volume62en_US
dc.identifier.wosWOS:000208660500009
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherEdizioni Minerva Medicaen_US
dc.relation.ispartofMinerva Pediatrica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcitretinen_US
dc.subjectIchthyosis, Lamellaren_US
dc.subjectInfanten_US
dc.titleTreatment of congenital ichthyosis with acitretin: a case reporten_US
dc.titleTreatment of congenital ichthyosis with acitretin: a case report
dc.typeArticleen_US

Dosyalar